Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
Author Correction: Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer.
Journal: NPJ breast cancer
Published: February 27, 2026
Modelling Immune Dynamics in Locally Advanced MSI-H/dMMR Colorectal Cancer with Neoadjuvant Pembrolizumab Treatment: From Differential Equations to an Agent-Based Framework.
Journal: Bulletin of mathematical biology
Published: September 16, 2025
Optimisation of pembrolizumab therapy for de novo metastatic MSI-H/dMMR colorectal cancer using data-driven delay integro-differential equations.
Journal: Journal of theoretical biology
Published: July 17, 2025
Lymphocytes and monocytes undergo swift suppression of IL-10R, IL-6R, and IL-2Rβγ signaling under high concentrations of different cytokines.
Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025
Optimisation of neoadjuvant pembrolizumab therapy for locally advanced MSI-H/dMMR colorectal cancer using data-driven delay integro-differential equations.
Journal: Journal of theoretical biology
Published: March 31, 2025
Ligand discrimination in immune cells: Signal processing insights into immune dysfunction in ER+ breast cancer.
Journal: PLoS computational biology
Published: March 17, 2025
Ligand Discrimination in Immune Cells: Signal Processing Insights into Immune Dysfunction in ER+ Breast Cancer.
Journal: bioRxiv : the preprint server for biology
Published: March 03, 2025
Baseline Tumor Features and Systemic Immune Dynamics Underlying Efficacy in MSS Metastatic Colorectal Cancer Treated with Regorafenib, Ipilimumab, and Nivolumab.
Journal: Cancer immunology research
Published: February 24, 2025
Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood.
Journal: NPJ systems biology and applications
Published: April 17, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.
Journal: Nature medicine
Published: February 04, 2024
The business case for quality: estimating lives saved and harms avoided in a value-based purchasing model.
Journal: Health affairs scholar
Published: January 29, 2024
Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood.
Journal: bioRxiv : the preprint server for biology
Published: November 14, 2023
Last Updated: 09/26/2026